Genomics – the study of the genetic makeup of an organism – helps researchers and oncologists pinpoint why there is no routine lung cancer.Read More

Genomics – the study of the genetic makeup of an organism – helps researchers and oncologists pinpoint why there is no routine lung cancer. Every lung cancer has a unique set of genetic abnormalities, and studying an individual’s genomics allows experts to gain insights into that person's unique cancer.Read More

Every day, experts at the OSUCCC – James are making advances in cancer research and treatment. These advances are especially important in cancers for which treatment is a challenge, like lung cancer.Read More

Every day, experts at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) are making advances in cancer research and treatment. These advances are especially important in cancers for which treatment is a challenge for oncologists, like lung cancer.Read More

Because researchers and clinicians at The Ohio State University understand that there is no routine cancer, their approach to treating this disease differs from how cancers were treated years ago.Read More

Because researchers and clinicians at The Ohio State University understand that no two cancers are alike and that there is no routine cancer, their approach to treating this disease differs from how cancers were treated years ago. In the past, cancers were characterized solely by their location - breast, lung, prostate, etc. However, in the past 10 years, researchers and oncologists have learned that cancer can also be classified by genetic changes.Read More

An estimated 46,420 people in the United States will be diagnosed with pancreatic cancer in 2014. Read More

An estimated 46,420 people in the United States will be diagnosed with pancreatic cancer in 2014. Fortunately, research experts at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) are constantly innovating to find new ways to treat the disease. Read More

One out of four individuals at high risk of lung cancer who receive a low-dose CT scan as part of the lung cancer screening process will have a spot on their lung. Read More

One out of four individuals at high risk of lung cancer who receive a low-dose CT scan as part of the lung cancer screening process will have a spot on their lung. Of those patients, 96.3 percent will be found to not have cancer. In many cases, the only way to confirm whether a spot is cancerous is an invasive procedure that can be expensive and stressful while possibly causing medical complications.Read More

Burden “Brent” Brunthall, 83, of Seattle, Wash., learned he had stage 4 cancer of the carotid gland in 2010.Read More

Burden “Brent” Brunthall, 83, of Seattle, Wash., learned he had stage 4 cancer of the carotid gland in 2010. After surgery to remove his salivary gland, followed by an aggressive radiation therapy regimen, doctors believed his cancer was in remission. Unfortunately, it showed up in his lymph nodes nine months later. Brunthall knew from his original workup that his tumor was human epidermal growth factor receptor-2 (HER-2) positive. Read More

For some women, it might be one virus well worth having. In fact, while it causes cold- or flu-like symptoms, the reovirus may help save lives...Read More

For some women, it might be one virus well worth having. In fact, while it causes cold- or flu-like symptoms, the reovirus may help save lives. And that’s what the gynecologic oncology research experts at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) mean to find out.Read More

Why ride, donate or volunteer for Pelotonia? The promise of Pelotonia is revealed in part by the discoveries made by teams of researchers at the OSUCCC – James who receive support from the annual event.Read More

Why ride, donate or volunteer for Pelotonia? The promise of Pelotonia is revealed in part by the discoveries made by teams of researchers at the OSUCCC – James who receive support from the annual event.Read More

One novel idea. Sometimes that’s all it takes to change a life. And sometimes, it just might save one.Read More

One novel idea. Sometimes that’s all it takes to change a life. David Carbone, MD, PhD, who was recruited to Ohio State to establish a Thoracic Oncology Center at the university’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research institute (OSUCCC – James), knows this firsthand. It was his idea that saved a patient’s life and changed what the experts look for when analyzing a patient’s tumor.Read More

At any given moment, there are about 700,000 individuals with brain or spinal cord tumors in the United States, and about 140,000 of those individuals have malignant tumors – cancer.Read More

At any given moment, there are about 700,000 individuals with brain or spinal cord tumors in the United States, and about 140,000 of those individuals have malignant tumors – cancer. Treatment options for brain cancer patients have been limited, but recent discoveries have proven effective in developing new treatments. Read More